Convatec

Convatec is a global medical products and technologies company that develops solutions for the management of chronic conditions. Founded in 1978, it evolved from a division of E.R. Squibb & Sons and is today listed on the London Stock Exchange as a FTSE 100 constituent, with annual revenues exceeding $2 billion and more than 10,000 colleagues. The group operates in around 90 countries and sits within the heavily regulated healthcare, medical devices and medical technology sectors.

The company's portfolio is organised around four areas: Advanced Wound Care, covering wound management, infection prevention and the protection of at-risk skin; Ostomy Care; Continence Care; and Infusion Care, covering infusion therapy and management. Its stated technical domains span chronic condition management, advanced wound care technology, skin protection and infection prevention, and medical device manufacturing.

Convatec describes its purpose as helping people with chronic health conditions lead the lives they want, with more mobility, confidence and freedom, and frames its culture around a promise of being "forever caring", combining trusted medical solutions with compassion for the people it serves. The company states a focus on improving patient outcomes while reducing care costs.